Jeffrey M. Leiden, Executive Chairman at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 188,738 shares at $272.41 ($50.9M) on 2020-05-07, disclosed to the SEC on 2020-05-08.
Open-market sale of $50.9M VRTX by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $267.52 | 5,892 | $1.6M | 3.1% |
| 2 | $267.52 | 5,892 | $1.6M | 3.1% |
| 3 | $268.63 | 24,617 | $6.6M | 13.0% |
| 4 | $268.63 | 24,617 | $6.6M | 13.0% |
| 5 | $269.52 | 30,237 | $8.1M | 16.0% |
| 6 | $269.52 | 30,237 |
| $8.1M |
| 16.0% |
| 7 | $270.43 | 13,885 | $3.8M | 7.4% |
| 8 | $270.43 | 13,885 | $3.8M | 7.4% |
| 9 | $271.61 | 14,131 | $3.8M | 7.5% |
| 10 | $271.61 | 14,131 | $3.8M | 7.5% |
| 11 | $272.41 | 5,607 | $1.5M | 3.0% |
| 12 | $272.41 | 5,607 | $1.5M | 3.0% |
| Total | $269.78 avg | 188,738 | $50.9M | 100% |
| Filing → |
| VRTX | SELL | 2025-11-17 | $64.1M | — | Filing → |
| VRTX | SELL | 2024-09-04 | $1.9M | — | Filing → |
| VRTX | SELL | 2024-02-16 | $7.6M | — | Filing → |